CD19 and B-cell chronic lymphocytic leukemia: Indeed, our IL-12 regulon score was positively associated with favorable clinical response in patients with chronic lymphocytic leukemia receiving anti-CD19 CAR-T-cell therapy (p = 0.007919; Fig. 7D).